vs
California BanCorp \ CA（BCAL）与Cytek Biosciences, Inc.（CTKB）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是California BanCorp \ CA的1.4倍（$62.1M vs $45.9M），California BanCorp \ CA净利率更高（35.8% vs -70.9%，领先106.7%），Cytek Biosciences, Inc.同比增速更快（8.1% vs 0.8%），California BanCorp \ CA自由现金流更多（$56.9M vs $-1.8M），过去两年California BanCorp \ CA的营收复合增速更高（44.7% vs 17.7%）
太平洋第一控股是依据美国1956年银行控股公司法案成立的美国银行控股集团，总部位于加利福尼亚州欧文市。集团核心业务围绕旗下太平洋第一银行展开，为个人、企业及专业人士提供各类金融服务，目前在加州、亚利桑那州、内华达州和华盛顿州开设了多家网点。
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
BCAL vs CTKB — 直观对比
营收规模更大
CTKB
是对方的1.4倍
$45.9M
营收增速更快
CTKB
高出7.3%
0.8%
净利率更高
BCAL
高出106.7%
-70.9%
自由现金流更多
BCAL
多$58.7M
$-1.8M
两年增速更快
BCAL
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.9M | $62.1M |
| 净利润 | $16.4M | $-44.1M |
| 毛利率 | — | 52.9% |
| 营业利润率 | 48.8% | -9.0% |
| 净利率 | 35.8% | -70.9% |
| 营收同比 | 0.8% | 8.1% |
| 净利润同比 | -2.1% | -557.1% |
| 每股收益（稀释后） | $0.50 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCALCTKB
| Q4 25 | $45.9M | $62.1M | ||
| Q3 25 | $45.2M | $52.3M | ||
| Q2 25 | $44.3M | $45.6M | ||
| Q1 25 | $44.8M | $41.5M | ||
| Q4 24 | $45.5M | $57.5M | ||
| Q3 24 | $38.1M | $51.5M | ||
| Q2 24 | $22.2M | $46.6M | ||
| Q1 24 | $21.9M | $44.9M |
净利润BCALCTKB
| Q4 25 | $16.4M | $-44.1M | ||
| Q3 25 | $15.7M | $-5.5M | ||
| Q2 25 | $14.1M | $-5.6M | ||
| Q1 25 | $16.9M | $-11.4M | ||
| Q4 24 | $16.8M | $9.6M | ||
| Q3 24 | $-16.5M | $941.0K | ||
| Q2 24 | $190.0K | $-10.4M | ||
| Q1 24 | $4.9M | $-6.2M |
毛利率BCALCTKB
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
营业利润率BCALCTKB
| Q4 25 | 48.8% | -9.0% | ||
| Q3 25 | 48.3% | -17.6% | ||
| Q2 25 | 45.3% | -23.3% | ||
| Q1 25 | 52.8% | -36.1% | ||
| Q4 24 | 52.2% | 5.2% | ||
| Q3 24 | -59.1% | -8.2% | ||
| Q2 24 | 1.3% | -18.3% | ||
| Q1 24 | 33.1% | -23.9% |
净利率BCALCTKB
| Q4 25 | 35.8% | -70.9% | ||
| Q3 25 | 34.7% | -10.5% | ||
| Q2 25 | 31.8% | -12.2% | ||
| Q1 25 | 37.6% | -27.5% | ||
| Q4 24 | 37.7% | 16.8% | ||
| Q3 24 | -43.2% | 1.8% | ||
| Q2 24 | 0.9% | -22.4% | ||
| Q1 24 | 22.5% | -13.8% |
每股收益（稀释后）BCALCTKB
| Q4 25 | $0.50 | — | ||
| Q3 25 | $0.48 | — | ||
| Q2 25 | $0.43 | — | ||
| Q1 25 | $0.52 | — | ||
| Q4 24 | $0.54 | — | ||
| Q3 24 | $-0.59 | — | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $0.26 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $399.9M | $90.9M |
| 总债务越低越好 | $33.8M | — |
| 股东权益账面价值 | $576.6M | $341.7M |
| 总资产 | $4.0B | $461.5M |
| 负债/权益比越低杠杆越低 | 0.06× | — |
8季度趋势，按日历期对齐
现金及短期投资BCALCTKB
| Q4 25 | $399.9M | $90.9M | ||
| Q3 25 | $559.2M | $93.3M | ||
| Q2 25 | $430.1M | $75.5M | ||
| Q1 25 | $439.2M | $95.3M | ||
| Q4 24 | $388.2M | $98.7M | ||
| Q3 24 | $614.4M | $162.3M | ||
| Q2 24 | $104.7M | $177.9M | ||
| Q1 24 | $86.5M | $168.8M |
总债务BCALCTKB
| Q4 25 | $33.8M | — | ||
| Q3 25 | $33.4M | — | ||
| Q2 25 | $52.9M | — | ||
| Q1 25 | $70.3M | — | ||
| Q4 24 | $69.7M | — | ||
| Q3 24 | $69.1M | — | ||
| Q2 24 | $42.9M | — | ||
| Q1 24 | $44.9M | — |
股东权益BCALCTKB
| Q4 25 | $576.6M | $341.7M | ||
| Q3 25 | $564.7M | $378.6M | ||
| Q2 25 | $547.6M | $377.6M | ||
| Q1 25 | $531.4M | $379.6M | ||
| Q4 24 | $511.8M | $395.7M | ||
| Q3 24 | $498.1M | $385.5M | ||
| Q2 24 | $293.2M | $389.1M | ||
| Q1 24 | $292.5M | $392.6M |
总资产BCALCTKB
| Q4 25 | $4.0B | $461.5M | ||
| Q3 25 | $4.1B | $494.9M | ||
| Q2 25 | $4.0B | $493.3M | ||
| Q1 25 | $4.0B | $482.6M | ||
| Q4 24 | $4.0B | $499.5M | ||
| Q3 24 | $4.4B | $491.2M | ||
| Q2 24 | $2.3B | $483.7M | ||
| Q1 24 | $2.3B | $492.1M |
负债/权益比BCALCTKB
| Q4 25 | 0.06× | — | ||
| Q3 25 | 0.06× | — | ||
| Q2 25 | 0.10× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.15× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.3M | $-771.0K |
| 自由现金流经营现金流 - 资本支出 | $56.9M | $-1.8M |
| 自由现金流率自由现金流/营收 | 124.1% | -2.9% |
| 资本支出强度资本支出/营收 | 0.8% | 1.6% |
| 现金转化率经营现金流/净利润 | 3.49× | — |
| 过去12个月自由现金流最近4个季度 | $93.1M | $-8.8M |
8季度趋势，按日历期对齐
经营现金流BCALCTKB
| Q4 25 | $57.3M | $-771.0K | ||
| Q3 25 | $16.0M | $-3.9M | ||
| Q2 25 | $13.4M | $108.0K | ||
| Q1 25 | $7.0M | $-125.0K | ||
| Q4 24 | $50.3M | $2.0M | ||
| Q3 24 | $18.3M | $13.2M | ||
| Q2 24 | $309.0K | $6.2M | ||
| Q1 24 | $8.1M | $4.0M |
自由现金流BCALCTKB
| Q4 25 | $56.9M | $-1.8M | ||
| Q3 25 | $15.9M | $-4.6M | ||
| Q2 25 | $13.4M | $-1.5M | ||
| Q1 25 | $6.9M | $-974.0K | ||
| Q4 24 | $49.7M | $1.1M | ||
| Q3 24 | $18.1M | $12.2M | ||
| Q2 24 | $171.0K | $5.2M | ||
| Q1 24 | $8.0M | $3.4M |
自由现金流率BCALCTKB
| Q4 25 | 124.1% | -2.9% | ||
| Q3 25 | 35.1% | -8.7% | ||
| Q2 25 | 30.2% | -3.2% | ||
| Q1 25 | 15.3% | -2.3% | ||
| Q4 24 | 109.2% | 1.9% | ||
| Q3 24 | 47.5% | 23.7% | ||
| Q2 24 | 0.8% | 11.0% | ||
| Q1 24 | 36.4% | 7.6% |
资本支出强度BCALCTKB
| Q4 25 | 0.8% | 1.6% | ||
| Q3 25 | 0.2% | 1.3% | ||
| Q2 25 | 0.1% | 3.5% | ||
| Q1 25 | 0.2% | 2.0% | ||
| Q4 24 | 1.2% | 1.6% | ||
| Q3 24 | 0.5% | 2.0% | ||
| Q2 24 | 0.6% | 2.3% | ||
| Q1 24 | 0.4% | 1.3% |
现金转化率BCALCTKB
| Q4 25 | 3.49× | — | ||
| Q3 25 | 1.02× | — | ||
| Q2 25 | 0.95× | — | ||
| Q1 25 | 0.41× | — | ||
| Q4 24 | 3.00× | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | 1.63× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCAL
暂无分部数据
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
